Match tier Listed
Presence Current · Arkansas
Last published 2025
Sources OpenAlex · ORCID
Refreshed 2026-08-17

Shemansky Jm

Researcher

Also affiliated: United States Food and Drug Administration (2025)

Graduate Student Researcher

1 pubs

  • Carcinogens
  • Neoplasms
  • Animals
  • Humans
  • Mutagenicity Tests
  • Clinical Trials, Phase I as Topic
  • Risk Assessment

Biography and Research Information

OverviewAI-generated summary

Shemansky Jm's research focuses on assessing carcinogenic outcomes following short-term exposure to potentially DNA-reactive drugs. This work investigates the sufficiency of available data for informing risk assessment in this area. The researcher's most recent publication was in 2025, indicating recent activity in the field.

Metrics

  • Publications: 1

Selected Publications

  • Assessing carcinogenic outcomes following short-term exposure to potentially DNA-reactive drugs: Are available data sufficient to inform risk assessment? (2025)
    Regulatory Toxicology and Pharmacology DOI OpenAlex

View all publications on OpenAlex →

Collaboration Network

4 Collaborators 3 Institutions 1 Country

Top Collaborators

View profile →
View profile →

Similar Researchers

Based on overlapping research topics